Akeso lung cancer drug helps patients live 15% longer than immunotherapy in China trial | Collector

Daily Monitor

Akeso lung cancer drug helps patients live 15% longer than immunotherapy in China trial

Global trial comparing ivonescimab to Keytruda expected to aid US approval